Peptide purity analysis by HPLC is one of the most routine yet technically demanding tasks in a research laboratory. Choosing the wrong column or gradient program can obscure impurities, collapse peaks, or produce irreproducible retention times that make lot-to-lot comparison impossible.
Why Column Choice Matters More for Peptides Than Small Molecules
Peptides occupy an awkward chemical space. They are larger than typical pharmaceutical small molecules but smaller than proteins, ranging roughly from 200 Da for dipeptides to 5,000 Da or more for longer sequences. This size range means standard C18 columns designed for drug-like compounds often perform poorly: peak tailing is common, and closely related impurities such as deamidation products or incomplete deprotection fragments co-elute.
The stationary phase must balance three competing demands:
- Sufficient hydrophobicity to retain peptides away from the solvent front
- Pore structure large enough to allow the analyte to access the stationary phase surface
- A surface chemistry that minimises secondary interactions with residual silanol groups
Stationary Phase Options
C18 (Octadecyl)
C18 remains the most widely used phase for peptide purity work. Fully endcapped, high-purity silica C18 columns reduce silanol interactions that otherwise cause tailing of basic residues such as lysine and arginine. Brands such as Waters Atlantis, Phenomenex Kinetex C18, or Agilent ZORBAX Eclipse C18 are frequently specified in method transfer documents.
C8 (Octyl)
C8 provides slightly less retention than C18, which is useful for very hydrophobic peptides that are difficult to elute at reasonable acetonitrile concentrations. Switching from C18 to C8 can shift a peptide from requiring 80% organic to roughly 65%, improving peak shape and column lifetime.
Phenyl and Phenyl-Hexyl
Phenyl phases add π–π selectivity, which improves resolution between aromatic-residue-containing peptides (phenylalanine, tyrosine, tryptophan). This can be decisive when a research peptide contains multiple aromatic residues that produce chemically similar byproducts.
Specialty Phases: Diphenyl and Polar-Embedded
Polar-embedded C18 phases tolerate highly aqueous mobile phases without phase collapse, which matters when gradient methods must begin at near-100% water to retain short, hydrophilic peptides. They also show slightly different selectivity for oxidised methionine versus unoxidised peptide, a common research-grade impurity.
Particle Size and Pore Diameter
| Parameter | Conventional | Sub-2 µm (UHPLC) |
|---|---|---|
| Particle size | 3–5 µm | 1.7–1.9 µm |
| Typical back pressure | < 400 bar | 400–1,000 bar |
| Run time advantage | Baseline | 2–4× faster |
| Resolution advantage | Baseline | Higher plate count |
Pore diameter is equally important. A 100 Å pore, standard for small-molecule work, restricts access for peptides above about 1,000 Da. Use 130–150 Å for peptides up to approximately 3,000 Da and 300 Å for longer sequences. The 300 Å pore is especially important when analysing crude synthetic peptide batches where high-molecular-weight deletion sequences may be present.
Mobile Phase Composition
Aqueous Phase
0.1% trifluoroacetic acid (TFA) in water is the industry standard for research peptide HPLC. TFA acts as an ion-pairing agent that pairs with protonated basic residues, increasing retention and improving peak symmetry. Formic acid (0.1%) is an alternative when downstream mass spectrometry is needed, though peak shapes are generally inferior to TFA.
Organic Modifier
Acetonitrile is preferred over methanol for most peptide work. It has a lower viscosity at high concentrations, a lower UV cutoff (190 nm vs 205 nm for methanol), and faster equilibration. Isopropanol can be added at 5–10% to the organic modifier to improve elution of very hydrophobic sequences.
Gradient Method Design
Starting Conditions
Begin at 2–5% acetonitrile (with 0.1% TFA) to ensure even the most hydrophilic impurities are retained. Starting too high causes early-eluting components to appear in the void volume, indistinguishable from unretained matrix components.
Gradient Slope
A linear gradient of 0.5–1% organic per minute is a practical starting point for unknown or complex peptide mixtures. Steeper gradients improve throughput but risk co-elution. Shallower gradients (0.25% per minute) improve resolution of closely related impurities such as mono-deamidation products, which differ from the target by only 1 Da.
Typical Gradient Programme for a Research Peptide (10–15 residues)
- 0–2 min: hold at 5% B
- 2–22 min: linear ramp to 45% B
- 22–24 min: ramp to 95% B (column wash)
- 24–26 min: hold at 95% B
- 26–28 min: return to 5% B
- 28–35 min: re-equilibration at 5% B
Adjust the upper limit based on the peptide’s calculated hydrophobicity. Highly hydrophobic sequences may require a ramp to 70–80% B.
Detection Wavelength
210–220 nm covers the peptide bond absorption and detects all residues. Monitoring at 280 nm simultaneously adds specificity for tryptophan- and tyrosine-containing peptides. Both channels should be recorded when a photodiode array detector is available.
Column Equilibration and Temperature
Allow at least 10–15 column volumes of starting mobile phase before injecting. Column temperature is often overlooked: running at 40–50°C lowers mobile phase viscosity, improves mass transfer, and typically sharpens peaks compared to ambient temperature. Temperature control also reduces day-to-day retention time variability.
Practical Starting Point for a New Peptide
Start with a 150 × 4.6 mm, 5 µm C18 column with 130 Å pores, 0.1% TFA in water versus 0.1% TFA in acetonitrile, a 1 mL/min flow rate, and a 0.5% per minute linear gradient from 5–50% organic. This covers the majority of research peptides between 10 and 30 residues and provides a reproducible reference point from which to optimise selectivity.
NXT Labs products are sold strictly as research chemicals for in vitro research, laboratory testing and analytical purposes only, and are not intended for use in any human or animal application.
Related reading
- Janoshik Analytical: A Practical Guide
- How to Verify a Third-Party Peptide Lab Test Report Is Genuine (And Not Fabricated)
- Peptide Stability in Solution
Order research peptides from NXT Labs
NXT Labs supplies research peptides for laboratory research use, with third-party batch testing at a U.S.-based lab. Frequently ordered: BPC-157, TB-500, GHK-Cu and bacteriostatic water.
Browse the full range or view current Certificates of Analysis. Research use only.
